Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06426693 · ClinicalTrials.gov registry record · NA

Craving Network Neurofeedback

A NA study of Overweight or Obesity, sponsored by Yale University.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06426693: Recruiting NA study of Overweight or Obesity, sponsored by Yale University.

NCT06426693 is a NA study of Overweight or Obesity that is actively recruiting participants, run by Yale University. The registered enrollment target is 50 participants, below the 31,711-participant average among 32 other Overweight or Obesity trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06426693, a NA study of Overweight or Obesity, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This project tests whether individuals with overweight or obesity and high craving can learn to change their brain response to food cues using neurofeedback, to impact their craving and eating behavior.

Primary Outcome

Craving network strength will be measured during transfer (i.e., no feedback) runs and compared across scan sessions.

Conditions Studied

Interventions

  • DEVICE Experimental feedback
  • DEVICE Control feedback

Study Locations (1)

Connecticut

  • Yale MRRC Anlyan Center - New Haven

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-11-27
Est. Completion 2027-03-31
Phase NA
Yale University

1,492 total trials

What NCT06426693 shows while recruiting

NCT06426693 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 31,711-participant average among 32 other Overweight or Obesity trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Overweight or Obesity appearing as the primary indexed condition, and to 2 interventions - of which Experimental feedback is the first listed.

NCT06426693 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT06426693 about?

NCT06426693 is a clinical study titled "Craving Network Neurofeedback". This project tests whether individuals with overweight or obesity and high craving can learn to change their brain response to food cues using neurofeedback, to impact their craving and eating behavior.

What is the current status of trial NCT06426693?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-11-27. Estimated completion is 2027-03-31.

What conditions does trial NCT06426693 study?

This clinical trial studies the following conditions: Overweight or Obesity.

What interventions are being tested in trial NCT06426693?

The interventions under investigation include: Experimental feedback (DEVICE), Control feedback (DEVICE).

Who is sponsoring clinical trial NCT06426693?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06426693 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight or Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06426693's enrollment target sits among peer trials

50 26th of 32 higher than 7 of 32 other Overweight or Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Overweight or Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06426693, the US trial registry maintained by the National Library of Medicine. NCT06426693 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.